Style | Citing Format |
---|---|
MLA | Brogi S, et al.. "In Silico Identification of Natural Products and World-Approved Drugs Targeting the Keap1/Nrf2 Pathway Endowed With Potential Antioxidant Profile." Computation, vol. 11, no. 12, 2023, pp. -. |
APA | Brogi S, Guarino I, Flori L, Sirous H, Calderone V (2023). In Silico Identification of Natural Products and World-Approved Drugs Targeting the Keap1/Nrf2 Pathway Endowed With Potential Antioxidant Profile. Computation, 11(12), -. |
Chicago | Brogi S, Guarino I, Flori L, Sirous H, Calderone V. "In Silico Identification of Natural Products and World-Approved Drugs Targeting the Keap1/Nrf2 Pathway Endowed With Potential Antioxidant Profile." Computation 11, no. 12 (2023): -. |
Harvard | Brogi S et al. (2023) 'In Silico Identification of Natural Products and World-Approved Drugs Targeting the Keap1/Nrf2 Pathway Endowed With Potential Antioxidant Profile', Computation, 11(12), pp. -. |
Vancouver | Brogi S, Guarino I, Flori L, Sirous H, Calderone V. In Silico Identification of Natural Products and World-Approved Drugs Targeting the Keap1/Nrf2 Pathway Endowed With Potential Antioxidant Profile. Computation. 2023;11(12):-. |
BibTex | @article{ author = {Brogi S and Guarino I and Flori L and Sirous H and Calderone V}, title = {In Silico Identification of Natural Products and World-Approved Drugs Targeting the Keap1/Nrf2 Pathway Endowed With Potential Antioxidant Profile}, journal = {Computation}, volume = {11}, number = {12}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Brogi S AU - Guarino I AU - Flori L AU - Sirous H AU - Calderone V TI - In Silico Identification of Natural Products and World-Approved Drugs Targeting the Keap1/Nrf2 Pathway Endowed With Potential Antioxidant Profile JO - Computation VL - 11 IS - 12 SP - EP - PY - 2023 ER - |